4.71
price down icon0.84%   -0.04
after-market Dopo l'orario di chiusura: 4.71
loading
Precedente Chiudi:
$4.75
Aprire:
$4.75
Volume 24 ore:
404.91K
Relative Volume:
0.39
Capitalizzazione di mercato:
$321.08M
Reddito:
-
Utile/perdita netta:
$-27.03M
Rapporto P/E:
-8.4107
EPS:
-0.56
Flusso di cassa netto:
$-23.97M
1 W Prestazione:
+10.43%
1M Prestazione:
+14.32%
6M Prestazione:
-10.80%
1 anno Prestazione:
+103.90%
Intervallo 1D:
Value
$4.58
$4.78
Intervallo di 1 settimana:
Value
$4.30
$4.975
Portata 52W:
Value
$2.30
$10.00

Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile

Name
Nome
Corvus Pharmaceuticals Inc
Name
Telefono
(650) 900-4520
Name
Indirizzo
863 MITTEN ROAD, BURLINGAME, CA
Name
Dipendente
31
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-25
Name
Ultimi documenti SEC
Name
CRVS's Discussions on Twitter

Confronta CRVS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRVS
Corvus Pharmaceuticals Inc
4.71 366.29M 0 -27.03M -23.97M -0.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-02 Iniziato H.C. Wainwright Buy
2023-08-18 Iniziato Oppenheimer Outperform
2021-12-01 Ripresa Jefferies Buy
2021-05-27 Iniziato Cantor Fitzgerald Overweight
2021-02-10 Downgrade Mizuho Buy → Neutral
2019-09-12 Iniziato Mizuho Buy
2019-05-29 Iniziato ROTH Capital Buy
2017-08-24 Aggiornamento Credit Suisse Underperform → Neutral
2017-05-01 Downgrade Credit Suisse Neutral → Underperform
2016-04-18 Iniziato Credit Suisse Outperform
2016-04-18 Iniziato Guggenheim Buy
Mostra tutto

Corvus Pharmaceuticals Inc Borsa (CRVS) Ultime notizie

pulisher
Jul 27, 2025

Is Corvus Pharmaceuticals Inc. stock overvalued or undervaluedMaximize returns with strategic stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost Corvus Pharmaceuticals Inc. Stock in 2025Defensive Stock Picks with Upside - Metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

How Corvus Pharmaceuticals Inc. stock performs during market volatilityHigh Return Stock Alerts - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why Corvus Pharmaceuticals Inc. stock attracts strong analyst attentionTriple Digit Return Forecasts - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How does Corvus Pharmaceuticals Inc. generate profit in a changing economySuperior return velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Corvus Pharmaceuticals Inc. Stock a Smart Buy in 2025 Investment Analysis InsideRisk Controlled Trading Ideas - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Corvus Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low-Risk Investment Plans - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Corvus Pharmaceuticals Inc. stock compared to the marketRapid growth opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Corvus Pharmaceuticals Inc. stock price move sharplyMarket Timing Advice - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is Corvus Pharmaceuticals Inc. stock a growth or value playRapid-fire capital growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Corvus Pharmaceuticals Inc. stock priceSuperior profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Corvus Pharma Bets On Immunotherapy And Analyst Optimism - Finimize

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Corvus Pharmaceuticals Inc. stockPhenomenal capital gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Corvus Pharmaceuticals Inc. a good long term investmentFree AI-Backed Trading Signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Corvus Pharmaceuticals Inc. Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 09, 2025

Analysts Are Bullish on Top Healthcare Stocks: Sandoz Group Ltd (SDZXF), Merit Medical Systems (MMSI) - The Globe and Mail

Jul 09, 2025
pulisher
Jul 08, 2025

Corvus 'Undervalued' Following Atopic Dermatitis Data From Apogee, Mizuho Securities Says - MarketScreener

Jul 08, 2025
pulisher
Jul 03, 2025

Corvus Pharmaceuticals’ Promising Study on Soquelitinib for Atopic Dermatitis - TipRanks

Jul 03, 2025
pulisher
Jul 02, 2025

Corvus Pharmaceuticals: Insider Confidence and Clinical Catalysts Fueling Growth - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

OrbiMed Advisors sells Corvus Pharma (CRVS) shares worth $4.89 million - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Corvus Pharmaceuticals, Inc.(NasdaqGM: CRVS) added to Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 25, 2025

Corvus Pharmaceuticals (CRVS) Gains China Approval for Soquelitinib Trial | CRVS Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Major Breakthrough: Corvus Expands Atopic Dermatitis Drug Development into Chinese Market with New Trial Approval - Stock Titan

Jun 25, 2025
pulisher
Jun 18, 2025

Financial Metrics Exploration: Understanding Corvus Pharmaceuticals Inc (CRVS) Through Ratios - DWinneX

Jun 18, 2025
pulisher
Jun 13, 2025

Corvus Pharmaceuticals: Multiple Opportunities, But Plenty Of Risk - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

Corvus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 11, 2025

Breakthrough Systemic Sclerosis Treatment Shows Promise in Top EULAR Study | CRVS Stock News - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress - TradingView

Jun 11, 2025
pulisher
Jun 10, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jun 10, 2025

Corvus Pharmaceuticals Inc Azioni (CRVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):